CHICAGO, Might 02, 2022–(BUSINESS WIRE)–Meitheal Pharmaceuticals (“Meitheal”), a completely built-in generic injectables firm primarily based in Chicago, Illinois as we speak introduced it has joined The Affiliation for Accessible Medicines (AAM), the commerce affiliation representing the generics and biosimilars trade. AAM works to make sure extra accessibility to generic and biosimilar medicines, and to advance insurance policies that promote sustainability of the accessible medicines trade.
“We’re proud to companion with AAM in assist of our mission to bridge essential gaps in healthcare with an inexpensive and diversified vary of generic injectables,” stated Tom Shea, Chief Government Officer of Meitheal Prescription drugs. “We stay up for working collectively to realize our shared aim of getting protected, efficient, and more-affordable medicines out of the lab and into the palms of the individuals who want them.”
“Meitheal’s lively engagement in AAM makes our voice even stronger and more practical as we advocate on behalf of the generic trade and its mission to make sure that our high quality, protected, efficient and inexpensive medicines are accessible to America’s sufferers,” stated Dan Leonard, Chief Government Officer of AAM. “We’re happy to welcome Tom Shea’s participation on our Board of Administrators alongside his trade friends.”
Meitheal primarily specializes within the improvement, manufacture, procurement, and sale of generic injectable prescribed drugs, with 36 FDA-approved merchandise overlaying indications for anti-infective, oncolytic, and intensive care. Moreover, Meitheal has an increasing product portfolio and sturdy pipeline, together with single and multi-dose vials, ready-to-use prefilled syringes and premixed baggage. As of the top of March 2022, Meitheal had 49 merchandise within the analysis and improvement part, 24 merchandise have been below overview by the US Meals and Drug Administration (FDA), and 16 merchandise have been deliberate to be launched in 2022.
ABOUT MEITHEAL PHARMACEUTICALS
Since 2017, Meitheal Prescription drugs has bridged important gaps within the US healthcare market by supplying top quality, inexpensive generic injectables. Our diversified product vary — from antibiotics, anticoagulants, and muscle relaxants to medicine utilized in chemotherapy — represents sensible options for numerous sufferers across the nation, in addition to Meitheal’s dedication to their care. Primarily based in Chicago, Illinois, our goal every day is producing high quality and guaranteeing affordability, utilizing the normal Irish tenet we’re named for — Meitheal (Mee·corridor): working collectively towards a standard aim, for the higher good.
Study extra about who we’re and what we do at www.meithealpharma.com.
AAM is pushed by the assumption that entry to protected, high quality, efficient medication has an amazing affect on an individual’s life and the world round them. Generic and biosimilar medicines enhance folks’s lives, enhancing society and the economic system in flip. AAM represents the producers and distributors of completed generic prescribed drugs and biosimilars, producers and distributors of bulk pharmaceutical chemical substances, and suppliers of different items and companies to the generic trade. Generic prescribed drugs are 90 p.c of prescriptions allotted within the U.S. however only 18 percent of whole drug spending.
ABOUT THE BIOSIMILARS COUNCIL
The Biosimilars Council, a division of the Affiliation for Accessible Medicines (AAM), works to make sure a constructive surroundings for affected person entry to biosimilar medicines. The Biosimilars Council is a number one supply for details about the security and efficacy of extra inexpensive alternate options to pricey model biologic medicines. Areas of focus embrace public and well being knowledgeable training, strategic partnerships, authorities affairs, authorized affairs, and regulatory coverage. Extra info is accessible at www.biosimilarscouncil.org.
View supply model on businesswire.com: https://www.businesswire.com/news/home/20220502005114/en/
Meitheal Prescription drugs, Inc.
Anne Renick, VP of Company Technique
224 443 4520